Skip to content

Objective Markers of Pain Perception in Humans

Objective Markers of Pain Perception in Humans: a Study in Healthy Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02559999
Enrollment
21
Registered
2015-09-25
Start date
2014-06-04
Completion date
2018-02-28
Last updated
2018-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Healthy Volunteers, Pain, EEG

Brief summary

Determine objective markers of pain perception remains a major scientific and medical issue. Various tools have been proposed to objectify pain, but their adaptability to different clinical contexts are limited. Our working hypothesis considers that the research for markers of immediate pain perception should be based on an electrophysiological approach, based on the combined analysis of EEG and autonomic responses.

Detailed description

This project aims to study the cortical and autonomic responses induced by tonic painful stimulation compared to those induced by comparable sensory and stressful stimulations, by combining high density EEG, cutaneous sympathetic, cardiovascular and pupillary recordings.

Interventions

OTHERPainful tonic stimuli
OTHERnon-painful stimuli

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Affiliate or beneficiary of social security * Signature of consent

Exclusion criteria

* History of cardiovascular disease (vagal syncope, hypertension, etc ...), renal, metabolic (diabetes ...), psychiatric (depression, etc ...) or neurological (seizure, etc ...) syndromes; * Reynaud's syndrome; * Raynaud's disease; * Acrocyanosis; * Known rhythm disorders; * Participation at the same time in another clinical trial; * Taking a medical treatment; * Suffering from acute (complaint of pain in the week before the test) or chronic pain, * Allergic to conductive gel for electrodes.

Design outcomes

Primary

MeasureTime frameDescription
EEG Gamma power.BaselineThe EGG signals are compared between a painful stimuli tonic to those evoked by non-painful stimuli.

Secondary

MeasureTime frameDescription
ratio of low to high frequency spectral powersBaselineThe low and high frequency spectral powers are measured by an ECG Holter. The ratio are compared between a painful stimuli tonic to those evoked by non-painful stimuli.
Magnitude of the sympathetic cutaneous reactivityBaselineThe sympathetic cutaneous reactivity is measured by an acquisition system (ME6000, MEDIMEX, France) with one electrode on the hand. The magnitudes are compared between a painful stimuli tonic to those evoked by non-painful stimuli.
Amplitude of pupillary dilationBaselineThe pupillary dilation is measured by the ISCAN® system (MA, USA). The amplitudes are compared between a painful stimuli tonic to those evoked by non-painful stimuli.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026